Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guohong Han

Showing results (151-160 of 200) with videos related to

Pageof 20
Sort By:
Journal of Hepatology|May 4, 2023
TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysisHélène Larrue, Gennaro D'Amico, Pol Olivas, et al.
Academic Radiology|August 5, 2018
Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic ShuntLong-Biao Cui, Shuyao Ren, Yi-Bin Xi, et al.
Hepatology (Baltimore, Md.)|October 2, 2023
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysisOana Nicoară-Farcău, Guohong Han, Marika Rudler, et al.
JHEP Reports : Innovation in Hepatology|March 22, 2022
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPSMenghao Li, Kai Li, Shihao Tang, et al.
Journal of Hepatology|August 24, 2024
Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleedingYong Lv, Qiuhe Wang, Bohan Luo, et al.
Journal of Hepatology|January 26, 2016
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialRiccardo Lencioni, Josep M Llovet, Guohong Han, et al.
International Journal of Cancer|April 3, 2016
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patientsYan Zhao, Hailiang Li, Wei Bai, et al.
European Journal of Gastroenterology & Hepatology|September 2, 2020
Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: assessment of ten prognostic modelsJing Li, Shihao Tang, Jianbo Zhao, et al.
Hepatology International|July 9, 2021
Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)Akash Shukla, Ananta Shreshtha, Amar Mukund, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2019
Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt CreationLuo Zuo, Yong Lv, Qiuhe Wang, et al.
Pageof 20

Showing results (151-160 of 200) with videos related to

Sort By:
Pageof 20
Journal of Hepatology|May 4, 2023
TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysisHélène Larrue, Gennaro D'Amico, Pol Olivas, et al.
Academic Radiology|August 5, 2018
Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic ShuntLong-Biao Cui, Shuyao Ren, Yi-Bin Xi, et al.
Hepatology (Baltimore, Md.)|October 2, 2023
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysisOana Nicoară-Farcău, Guohong Han, Marika Rudler, et al.
JHEP Reports : Innovation in Hepatology|March 22, 2022
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPSMenghao Li, Kai Li, Shihao Tang, et al.
Journal of Hepatology|August 24, 2024
Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleedingYong Lv, Qiuhe Wang, Bohan Luo, et al.
Journal of Hepatology|January 26, 2016
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialRiccardo Lencioni, Josep M Llovet, Guohong Han, et al.
International Journal of Cancer|April 3, 2016
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patientsYan Zhao, Hailiang Li, Wei Bai, et al.
European Journal of Gastroenterology & Hepatology|September 2, 2020
Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: assessment of ten prognostic modelsJing Li, Shihao Tang, Jianbo Zhao, et al.
Hepatology International|July 9, 2021
Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)Akash Shukla, Ananta Shreshtha, Amar Mukund, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2019
Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt CreationLuo Zuo, Yong Lv, Qiuhe Wang, et al.
Pageof 20